The hepatic apelin system: a new therapeutic target for liver disease - Wikidata - awgldk - TriplyDB

The hepatic apelin system: a new therapeutic target for liver disease

The hepatic apelin system: a new therapeutic target for liver disease

http://www.wikidata.org/entity/Q28295197

about

Adipokines - removing road blocks to obesity and diabetes therapy Angiogenesis and liver fibrosis The Role of the Apelin/APJ System in the Regulation of Liver Disease Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver.Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy.Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis Apelin serum level in Egyptian patients with chronic hepatitis C Adipokines as drug targets in diabetes and underlying disturbances.Clinical relevance of adipokines.Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.Headgroup-dependent membrane catalysis of apelin-receptor interactions is likely.The apelinergic system: a promising therapeutic target.Adipocytokines and hepatic fibrosis.Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth.Angiogenesis and Fibrogenesis in Chronic Liver Diseases.Effect of leptin and apelin preconditioning on hepatic ischemia reperfusion injury in rats.Apelin attenuates hyperoxic lung and heart injury in neonatal rats.Effects of apelin and leptin on renal functions following renal ischemia/reperfusion: An experimental study.Eggshell membrane ameliorates hepatic fibrogenesis in human C3A cells and rats through changes in PPARγ-Endothelin 1 signaling.Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes.Inflammatory markers should be assessed together with cardiovascular risk factors by clinicians in masked hypertension.Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity.Uric Acid level should be stratified in order to better evaluate inflammatory status.The Effect of Estrogen Replacement Therapy on Visceral Fat, Serum Glucose, Lipid Profiles and Apelin Level in Ovariectomized Rats.Apelin/APJ system: A key therapeutic target for liver disease.Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan.Effects of exercise-induced apelin levels on skeletal muscle and their capillarization in type 2 diabetic rats.Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.Type of arteriovenous fistula, NYHA class and apelin in hemodialyzed patients.Apelinergic System Structure and Function.Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats.Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia.Enhanced expressions of apelin on proliferative hepatic arterial capillaries in human cirrhotic liver.Involvement of the apelin receptor APJ in Fas-induced liver injury.Serum Apelin and Obesity-Related Complications in Egyptian Children

P2860

Q26995825-BD3F9CEA-4AC5-4FD5-BB1B-494E8BEEC434 Q28082569-05851852-ABE0-4882-ABCE-50608FF9D9CE Q33593335-7E2E4C7E-7B34-446F-B18D-1A26A93FA853 Q33666996-67EC0FCB-A667-402B-8807-369EA268A4EB Q33802693-DFCDD2BF-AB9F-487D-945C-11C71A533814 Q33990716-FB21E0D3-681A-44E5-9519-A583C00EE3F8 Q35169373-07C5253F-AB24-4B2B-B00D-AD3C9B143BD2 Q35294979-A15A26FF-526F-4A0A-95AD-0E5A75CF47F7 Q35415815-789E530F-0024-41C6-9612-DB3855D9D46D Q36365207-94FF709F-600B-4C9C-BCA8-C08657D94BD7 Q36412910-762F645B-7001-4C76-9400-A3A4771B1675 Q36526062-74E4BF0D-ACB6-448D-8FEF-97D15FA8C09E Q37330205-F57117E7-EC68-4D96-B39B-9B34E4542DFF Q37720708-EBBBA189-E24C-4426-88A9-B2D197656717 Q38346026-62D8EE5C-A2AC-4224-82FF-E750D4F279DC Q38728549-3CB6B5E2-7AAB-43C7-9A03-50FCEBE140F4 Q39140170-2C2FED81-1EF0-47A4-B917-26A7007F4B29 Q40104113-455057DB-D884-47CB-9545-9D00EC5F6F9C Q41137848-FEF3E112-0471-4CF0-B837-AFDF474E05EA Q42041139-99373890-DBA1-4EF6-BBAD-552A99BA4673 Q42292936-60F60ECD-496D-4C29-8431-0BA41FF25A7C Q42816993-062F4453-B052-4755-B137-B6AFA16E7EC0 Q43481104-97B28DCE-2D61-4FB3-BD2B-62B399227833 Q45238005-D10E55EA-68BF-4A43-811B-D7BFC80CC258 Q45817511-DA7D82E2-8599-4417-9B93-B012A833AF7F Q47550809-FC89B1C1-1A66-47A2-BE2D-C3693D6F964F Q49271659-D402CD29-B088-4817-8120-F4BC09606FE4 Q50104995-FC4432BE-5812-45F1-99B2-6D9979A8342D Q51151624-363643D5-6C59-4FB7-8DAB-C9F7FCE8FBD3 Q51308854-FC6A78D2-B98F-4066-8E80-9CB5FA612531 Q51775749-8B7A5A6B-8DF1-498B-B336-194B1F544816 Q53468087-AD9AA557-140E-4E27-9A6C-6A52578030D2 Q53816618-503A0FCC-72CD-4753-979E-02E8C1BF27AB Q54283252-43CBB2D7-540D-4255-8A07-3D4ACD254681 Q54314719-A1B89712-E190-4A2E-8653-D0F2612BF84A Q54473724-64872FBA-DED9-4630-8A0E-513B42741B47 Q58769053-75A82455-76D3-4F37-8244-46273D02C9EC

P2860

The hepatic apelin system: a new therapeutic target for liver disease

http://www.wikidata.org/entity/Q28295197

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The hepatic apelin system: a new therapeutic target for liver disease

@ast

The hepatic apelin system: a new therapeutic target for liver disease

@en

The hepatic apelin system: a new therapeutic target for liver disease

@nl

type

label

The hepatic apelin system: a new therapeutic target for liver disease

@ast

The hepatic apelin system: a new therapeutic target for liver disease

@en

The hepatic apelin system: a new therapeutic target for liver disease

@nl

prefLabel

The hepatic apelin system: a new therapeutic target for liver disease

@ast

The hepatic apelin system: a new therapeutic target for liver disease

@en

The hepatic apelin system: a new therapeutic target for liver disease

@nl

P1433

Q28295197-EBCCFC2B-3C88-4B14-A24B-18234692959F

P1476

Q28295197-E124E1BE-7875-4FFD-ACF0-1DC8D2D73D50

P2093

Q28295197-36612710-8CA6-48BF-9B25-34B02EDF0BCB

Q28295197-69DB6A52-BB90-4B84-A0C0-773239B17098

Q28295197-AFF2D176-C32A-42EB-9D41-BC2697071A2C

Q28295197-E0CAD5F9-A75A-410F-816D-106C2F6A51F8

Q28295197-E56D4A1D-BE7E-42D7-9EDA-769F4DA59D84

P2860

Q28295197-00729C30-3858-466D-9A49-6F561E4E965A

Q28295197-012B0183-DFA8-4572-837C-4544A790F979

Q28295197-054397E9-22D0-4177-8DD8-F760D68A7A0E

Q28295197-20E4C7DA-7A61-46F1-BF2E-D5CEFB218DFB

Q28295197-30BB81EA-EDEC-46AB-9E49-87DBDB5584BC

Q28295197-31B6B0EB-39A0-4D0C-A9A7-D779C11F5DE9

Q28295197-32673E96-436B-44A3-8B8E-CCAA89279785

Q28295197-401C8BDB-1EA1-4CE3-8500-2A4C68C382FD

Q28295197-4195EAFF-922E-4F4F-9D50-8980E04D1103

Q28295197-5CF847E0-4C5D-4F53-8584-0CF67C16C3C0

P304

Q28295197-0DD6762D-7265-4E81-8336-FDC3001DE63C

P31

Q28295197-1F5A378E-34BA-4CC3-A530-82DAA88318F3

P356

Q28295197-535ADFD0-04DA-4227-80AF-14DFD72D6345

P407

Q28295197-46728DD3-54B8-46E9-A2F5-3B130430A58A

P433

Q28295197-F3F9F16F-87EA-4295-B86E-3383D0A59988

P478

Q28295197-6E5F6C6A-FD4C-4FC1-B214-0973DC9D167F

P50

Q28295197-2E882F9B-A801-47FD-9901-6CE71E09CA5F

Q28295197-98530869-C519-477C-A74D-721A8D82EE07

Q28295197-D378F94B-9421-497F-AC2C-48E3511C7A2B

Q28295197-E452D7AC-09BD-473B-BDA5-B44EAC4D8952

P577

Q28295197-3682CEDE-D945-4016-822F-822F466AA215

P5875

Q28295197-B5F29818-00E8-4021-8A8F-72C12F00CDDD

P698

Q28295197-20F4AD14-95CC-48A2-BF6E-08D9334BB489

P356

P1433

P1476

The hepatic apelin system: a new therapeutic target for liver disease

@en

P2093

Alessandro Principe

http://www.w3.org/2001/XMLSchema#string

Guillermo Fernández-Varo

http://www.w3.org/2001/XMLSchema#string

Josefa Ros

http://www.w3.org/2001/XMLSchema#string

Luis Ruiz del Arbol

http://www.w3.org/2001/XMLSchema#string

Mauro Bernardi

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism

Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein

Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility

Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo

Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo

Modification of the terminal residue of apelin-13 antagonizes its hypotensive action

The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors

Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin

Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release

P304

1193-1201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22467

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Manuel Morales-Ruiz

Wladimiro Jiménez

Pedro Melgar-Lesmes

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23279109

http://www.w3.org/2001/XMLSchema#string

P698

18816630

http://www.w3.org/2001/XMLSchema#string